NCT05752175

Study of WPV01 Compared With Placebo in Patients With Mild/Moderate COVID-19 Infection

A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of WPV01 in Patients With Mild/Moderate COVID-19 Infection

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Westlake Pharmaceuticals (Hangzhou) Co., Ltd. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A randomized, double-blind, placebo-controlled phase II clinical study to evaluate the efficacy and safety of WPV01 in patients with mild/moderate COVID-19 infection

Conditions

• COVID-19 Infection

Interventions

Type	Name	Description
DRUG	WPV01	WPV01 tablets
DRUG	Placebo	Placebo tablets

Timeline

• Start date: 2023-03-10
• Primary completion: 2023-05-09
• Completion: 2023-07-03
• First posted: 2023-03-02
• Last updated: 2024-06-12

Locations

1 site across 1 country: China